CBDMD INC (YCBD)
US12482W3097 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.50M | 1.80M | 6.70M | 26.40M | 14.80M | |||
| Marketable Securities | N/A | N/A | 1.00M | 1.00M | 300.00K | |||
| Receivables | 1.10M | 1.22M | 1.40M | 1.10M | 900.00K | |||
| Inventories | 3.55M | 4.05M | 4.30M | 5.00M | 4.60M | |||
| Other Current Assets | 1.20M | 1.00M | 2.60M | 2.90M | 3.10M | |||
| Total Current Assets | 7.37M | 8.07M | 16.00M | 36.50M | 23.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.85M | 4.07M | 5.30M | 8.20M | 10.00M | |||
| Investments And Advances | 700.00K | 700.00K | 1.40M | N/A | N/A | |||
| Goodwill | N/A | N/A | 0.00 | 56.70M | 54.70M | |||
| Intangibles | 3.05M | 3.22M | 17.80M | 23.00M | 21.60M | |||
| Other Non-Current Assets | 132.20K | 138.71K | 200.00K | 500.00K | 800.00K | |||
| Total Non-Current Assets | 7.73M | 8.13M | 24.80M | 88.40M | 87.10M | |||
| TOTAL ASSETS | 15.10M | 16.20M | 40.80M | 124.90M | 110.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 2.49K | 0.00 | 100.00K | 900.00K | |||
| Accrued Expenses | 4.41M | 2.76M | 3.20M | 3.90M | 3.90M | |||
| Accounts Payable | 1.57M | 1.91M | 2.00M | 3.00M | 2.90M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 5.97M | 4.67M | 5.30M | 6.90M | 7.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 10.00 | 100.00K | 0.00 | 600.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 900.00K | |||
| Other Non-Current Liabilities | 2.09M | 2.49M | 4.00M | 14.80M | 22.50M | |||
| Total Non-Current Liabilities | 2.09M | 2.49M | 4.10M | 14.80M | 24.00M | |||
| TOTAL LIABILITIES | 8.06M | 7.16M | 9.40M | 21.70M | 31.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -176.36M | -174.36M | -147.40M | -73.30M | -47.40M | |||
| Additional Paid In Capital | 183.39M | 183.39M | 178.80M | 176.40M | 126.50M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 7.96K | 7.96K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 7.96M | 2.96M | 1.30M | 1.30M | 1.20M | |||
| Tangible Book Value per Share | 0.50 | 1.96 | 10.46 | 18.00 | 2.42 | |||
| Total Shareholders' Equity | 7.04M | 9.03M | 31.40M | 103.10M | 79.20M | |||
| TOTAL LIABILITIES AND EQUITY | 15.10M | 16.20M | 40.80M | 124.90M | 110.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | 0.00 | N/A | 0.01 | |||
| Current Ratio | 1.23 | 1.73 | 3.02 | 5.29 | 3.08 | |||
| Return On Assets (ROA) | -158.87% | -166.35% | -181.59% | -20.78% | 11.05% | |||
| Return On Equity (ROE) | -340.82% | -298.30% | -235.96% | -25.17% | 15.45% | |||
All data in USD